Trials / Conditions / Recurrent Pancreatic Adenocarcinoma
Recurrent Pancreatic Adenocarcinoma
5 registered clinical trials studyying Recurrent Pancreatic Adenocarcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and R NCT07226856 | Mayo Clinic | Phase 2 |
| Enrolling By Invitation | Early Recurrence After Surgery for Pancreatic Cancer NCT07241676 | Azienda Ospedaliera di Padova | — |
| Terminated | Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreat NCT04975516 | Mayo Clinic | Phase 2 |
| Completed | Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer NCT03910387 | Emory University | Phase 2 |
| Completed | Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer NCT02907099 | M.D. Anderson Cancer Center | Phase 2 |